Detecting Cancer with Silica Nanoparticles

Sep 18, 2006

Tumor necrosis factor-alpha is a widely accepted biomarker for cancer, but the minute amounts of this protein circulating in blood makes detecting the molecule and measuring its concentration accurately a technological challenge.

Using silica nanoparticles labeled with the molecule guanine, researchers at the Pacific Northwest National Laboratory have now created a simple and inexpensive electrochemical method that detects tumor necrosis factor-alpha (TNF-æ) at clinically useful levels. Moreover, this assay is amenable to miniaturization, suggesting that it could be easily incorporated into a microfluidics-based assay system.

Reporting its work in the journal Analytical Chemistry, a research team headed by Yuehe Lin, Ph.D., loaded guanine molecules onto the surface of silica nanobeads that also contained a chemical anchor known as avidin. They also attached biotin, which binds with extraordinary strength to avidin, to an antibody that binds to the TNF-æ protein. The researchers attached a second antibody, one that binds to a different part of the TNF-æ protein, to a carbon electrode, which functions as the electrochemical sensor.

When TNF-æ is present in a solution added to the antibody-labeled electrode, it binds to the antibody. Adding the second antibody produces a sandwich around the TNF-æ molecule. At this point, the researchers then added their labeled silica nanoparticle, which binds to the antibody-TNF-æ sandwich. In a final step, the investigators added a molecule that reacts with the guanines on the nanoparticle, creating an electrical current that the electrode senses. The current flowing into the electrode is proportional to the amount of TNF-æ bound to the first antibody. Experiments with this system showed that the limit of detection for the device is approximately 2 picomolar, well within the range needed to detect physiological levels of TNF-æ.

This work is detailed in a paper titled, “Sensitive immunoassay of a biomarker tumor necrosis factor-æ based on poly(guanine)-functionalized silica nanoparticle label.” This paper was published online in advance of print publication. An abstract of this paper is available at the journal’s website.

Source: National Cancer Institute

Explore further: New electronic stent could provide feedback and therapy—then dissolve

Related Stories

Recommended for you

Self-replicating nanostructures made from DNA

5 hours ago

(Phys.org)—Is it possible to engineer self-replicating nanomaterials? It could be if we borrow nature's building blocks. DNA is a self-replicating molecule where its component parts, nucleotides, have specific ...

Non-aqueous solvent supports DNA nanotechnology

May 27, 2015

Scientists around the world are using the programmability of DNA to assemble complex nanometer-scale structures. Until now, however, production of these artificial structures has been limited to water-based ...

Nanosilver and the future of antibiotics

May 27, 2015

Precious metals like silver and gold have biomedical properties that have been used for centuries, but how do these materials effectively combat the likes of cancer and bacteria without contaminating the ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.